Reliance Life Sciences to Expand Biopharma and Pharma Businesses

Reliance Life Sciences (RLS; Mumbai), a Reliance Industries subsidiary, says it plans to expand its biopharmaceuticals and pharmaceuticals business. The company intends to establish a manufacturing facility in India to produce generic drugs that will focus on supplying international, regulated markets. RLS also is working to develop several biopharma products, a few of which will be launched in early 2008, the company says. “We are planning an active pharmaceutical ingredient and formulation facility for manufacturing generic pharmaceuticals,” says KV...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers